SP
LFST icon

Stockbridge Partners’s Lifestance Health LFST Stock Holding History

Stockbridge Partners’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,813,215
Closed -$19.3M – 15
2023
Q3 		$19.3M Sell
2,813,215
-873,937
-24% -$7.08M 0.43% 15
2023
Q2 		$33.7M Sell
3,687,152
-3,049,538
-45% -$25.3M 0.69% 15
2023
Q1 		$50.1M Sell
6,736,690
-419,712
-6% -$2.33M 1.16% 14
2022
Q4 		$35.4M Buy
7,156,402
+325,265
+5% +$2.01M 0.95% 13
2022
Q3 		$45.2M Buy
6,831,137
+15,000
+0.2% +$105K 1.28% 13
2022
Q2 		$37.9M Buy
6,816,137
+1,521,527
+29% +$11.7M 0.99% 16
2022
Q1 		$53.5M Buy
+5,294,610
New +$46.5M 1.16% 15

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stockbridge Partners's LFST Position: Q4 2023 in Review

Stockbridge Partners sold out of Lifestance Health (LFST) in Q4 2023, closing a stake of 2,813,215 shares — an estimated $19.3M sold.

Stockbridge Partners first reported a position in LFST in Q1 2022 and held it in 7 quarters. The position peaked at $53.5M in Q1 2022. 120 funds tracked by Wall St. Rank hold LFST as of Q4 2023.

  • Stockbridge Partners reported no remaining Lifestance Health position as of Q4 2023 after selling out during the quarter.
  • Stockbridge Partners sold 2,813,215 Lifestance Health shares in Q4 2023, an estimated $19.3M.
  • Stockbridge Partners first reported a position in Lifestance Health in Q1 2022 and held it in 7 quarters.
  • Stockbridge Partners's Lifestance Health position peaked at $53.5M in Q1 2022.
  • 120 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2023.

Based on Stockbridge Partners's 13F filing for Q4 2023, filed 14 Feb 2024.